This is a snippet of the transcript.Contact Salesto get full access.
When we looked at Blackline, one thing we liked was their focus on software and recurring revenue. Honeywell traditionally has a strong tie to hardware. The sales teams love to sell hardware, and the R&D team loves the hardware aspect. The whole innovation engine has been centered around hardware, so pivoting to more software is not easy and doesn't happen simultaneously across the board. When we looked at Blackline, we liked their software platform and how their story was straightforward compared to ours, which was complex and sometimes buried in a higher-level narrative. You had to talk about the whole business, and then three layers down, you get to safety, which is comparable to Blackline. Blackline had that advantage.
This is a snippet of the transcript.Contact Salesto get full access.
I think that's the tendency. I don't think it's imminent. What I mean is, I don't think it's going to happen in the next couple of years. But, for example, would you sell the hardware and provide the software at cost or no cost, or would you lease the hardware with the software and charge a subscription? There were many discussions about what's going to happen. I think what's tricky for the commoditization of the software is really the regulatory environment in some cases. In some countries and industries, as you know, some of those solutions make it easier for certain industries and countries, while others don't. So, I think it's going to take time to achieve broader commoditization.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research